Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Pharmacology in nuclear medicine Prof Geoff Currie, BPharm, MMedRadSc, MAppMngt, MBA, PhD Faculty of Science, Charles Sturt University Faculty of Medicine and Health Sciences, Macquarie University Rural Clinical School, University of NSW May 28 – 30, 2015, Montréal, Québec FACULTY OF SCIENCE Disclosure Statement: No Conflict of Interest I do not have an affiliation, financial or otherwise, with a pharmaceutical company, medical device or communications organization. I have no conflicts of interest to disclose ( i.e. no industry funding received or other commercial relationships). I have no financial relationship or advisory role with pharmaceutical or device-making companies, or CME provider. I will not discuss or describe in my presentation at the meeting the investigational or unlabeled ("off-label") use of a medical device, product, or pharmaceutical that is classified by Health Canada as investigational for the intended use. May 28 – 30, 2015, Montréal, Québec FACULTY OF SCIENCE Pharmacology • is the study of the action of drugs on living systems and the interactions of drugs with living systems • Generally is divided into • • Pharmacodynamics is the effects of the drug on the body Pharmacokinetics is the effects of the body on drugs FACULTY OF SCIENCE FACULTY OF SCIENCE Drug • is a chemical substance that produces a biological effect and can be either synthetic or derived from plant, animal or mineral sources • Generally is exogenous although endogenous sources might also exist • for example, adenosine is an endogenous drug produced by the body while dipyridamole is an exogenous drug introduced to the body FACULTY OF SCIENCE Receptor Principles • Receptors are proteins (macromolecules) that mediate drug activity • The chemical signal (ligand) binds to a specific site (receptor) and triggers a response in the cells • The intra-cellular changes initiated by the ligand-receptor complex can be through direct or indirect action, however, the ligand generally functions as an agonist or an antagonist FACULTY OF SCIENCE Receptor Principles • An agonist will mimic the endogenous ligand to produce a similar response • An antagonist blocks the usual ligand and, thus, inhibits the physiological response • • • • • Antagonist can be reversible, partially reversible or irreversible Caffeine / adenosine Beta blockers CCB Captopril (ACEI) FACULTY OF SCIENCE Receptor Concept - Agonist FACULTY OF SCIENCE Receptor Concept - Antagonist No response FACULTY OF SCIENCE Receptor Principles • Specificity is the measure of a receptors ability to respond to a single ligand • Low specificity generally results in physiological responses not targeted or intended by the drug; side effects provide a good example • Selectivity defines the ability of the receptor to distinguish between drugs and has the same implications as specificity; indeed the terms are often used interchangeably FACULTY OF SCIENCE Receptor Principles • Affinity defines the strength of attraction between the drug and its receptor • A high affinity is generally associated with a lower dose requirement (compared to low affinity for the same receptor). • Potency describes the relationship between the drug dose and the magnitude of the effect • • High potency induces a maximum effect with a minimum of drug. Antagonist potency relates to dose required to inhibit 50% of biological effect of agonist FACULTY OF SCIENCE Receptor Principles • Efficacy is the invivo potency • Antagonist has no efficacy • The interaction (eg. absorption, metabolism, excretion) of the drug in the body may alter the relative bioavailability and thus, change the theoretical effect of the drug. FACULTY OF SCIENCE FACULTY OF SCIENCE Pharmacodynamics • Used to explain the relationship between the drug dose and response • • Drug effects Side effects • The pharmacologic response depends on: • • • • • Drug binding to the target. Concentration of the drug at the receptor site. Disease states Age and gender Other drugs FACULTY OF SCIENCE Dose-Response Relationships • Concentration of the drug at the receptor controls the effect • Typically non-linear • Drug effect is a function of dose and time FACULTY OF SCIENCE Increased efficacy Increased potency FACULTY OF SCIENCE Antagonist (eg caffeine on adenosine) FACULTY OF SCIENCE FACULTY OF SCIENCE Therapeutic Window FACULTY OF SCIENCE Pharmacokinetics • The underlying principle of pharmacokinetics is consistent with the philosophy of Paracelsus (medieval alchemist) “only the dose makes a thing not a poison” • Within a window, a specific drug will offer therapeutic benefit and outside that window there will either be no therapeutic benefit or toxicity. FACULTY OF SCIENCE Pharmacokinetics • A narrow therapeutic range (eg digoxin) means small variations in blood concentration may easily result in toxic or sub therapeutic concentrations. • To maintain concentrations within the therapeutic range requires consistent bioavailability. FACULTY OF SCIENCE Pharmacokinetics - ADME • Absorption • Drug moves from site of administration to site of measurement • Distribution • Reversible drug transfer too and from site of measurement (eg. compartments) • Metabolism • Conversion of one species to another (eg. metabolites) • Excretion • Irreversible loss of drug from site of measurement (eg. kidneys, biliary, bowel) FACULTY OF SCIENCE FACULTY OF SCIENCE FACULTY OF SCIENCE FACULTY OF SCIENCE 2 compartment FACULTY OF SCIENCE FACULTY OF SCIENCE Calculations A patient weighing 70kg is given an IV bolus injection of 25mg of MDP. Plasma concentrations after injection are tabulated. Time (hours) Plasma concentration (micrograms / L) 139 65.6 31.1 14.6 2 4 6 8 160 140 120 100 80 60 40 20 0 Cp 0 2 4 6 8 10 FACULTY OF SCIENCE Calculations 1.Calculate the elimination rate constant and half life. Log / linear plot to confirm a single compartment mono-exponential curve. Time (hours) Plasma concentration (micrograms / L) 139 65.6 31.1 14.6 2 4 6 8 Log Cp 2.14 1.82 1.49 1.16 1000 100 Cp 10 1 0 2 4 6 8 10 FACULTY OF SCIENCE Calculations Calculate the k and half life C = C0 e-kt k = ln2 / T0.5 14.6 = 139 e-k.6 T0.5 = ln2 / k 14.6 / 139 = e-k.6 T0.5 = ln2 / 0.3745 ln 0.1057 = -k.6 T0.5 = 1.85 hours k = 0.3745 FACULTY OF SCIENCE Calculations Calculate the AUC0-∞ AUC0-∞ = Cp0 / k given k, C = C0 e-kt 139 = C0 e-0.3745 x 2 139 = C0 x 0.4728 C0 = 139 / 0.4728 C0 = 294 AUC0-∞ = 294 / 0.3745 = 785ug or 0.785 mghrs / litre FACULTY OF SCIENCE Calculations Calculate the clearance. CL = dose / AUC CL = 25000 / 785 CL = 31.84 litres / hour FACULTY OF SCIENCE Calculations The kidney concentrations of an IV DTPA are presented. Time (min) Plasma concentration (U / L) 0 31.3 49.3 58.6 62.5 62.8 58.1 50.6 36.1 25.3 0 1 2 3 4 5 7 10 16 24 70 60 50 40 Cp 30 20 10 24 22 20 18 16 14 12 10 8 6 4 2 0 0 FACULTY OF SCIENCE Calculations Calculate the elimination rate constant and half life. Log / linear plot to show mono-exponential clearance. 100 Cp 10 24 22 20 18 16 14 12 10 8 6 4 2 0 1 FACULTY OF SCIENCE Calculations Time (mins) 0 1 2 3 4 5 7 10 16 24 Plasma concentration (U / L) 0 31.3 49.3 58.6 62.5 62.8 58.1 50.6 36.1 25.3 Elimination curve concentration 58.1 50.6 36.1 25.3 So. C = C0 e-kt 25.3 = 58.1 e-k x 17 25.3 / 58.1 = e-k x 17 ln 0.4355 = -k x 17 k = 0.0489 (mins-1) k = ln2 / T0.5 T0.5 = ln2 / k T0.5 = ln2 / 0.0489 T0.5 = 14.17 mins FACULTY OF SCIENCE Calculations Calculate the absorption dose rate constant and half life. Elimination curve concentration 81.8 77.9 74.0 70.7 67.1 64.1 58.1 50.6 36.1 25.3 R (plasma – elim) 81.8 46.6 24.7 12.1 4.6 1.3 C = C0 e-ka x t 12.1 = 46.6 e-ka x 2 12.1 / 46.6 = e-ka x 2 ln 0.2596 = -ka x 2 ka = 0.6742 (mins-1) ka = ln2 / T0.5 T0.5 = ln2 / ka T0.5 = ln2 / 0.6742 T0.5 = 1.03 Mins 100 Cp 10 Log Cp 24 22 20 18 16 14 12 10 8 6 4 1 2 0 1 2 3 4 5 7 10 16 24 Plasma concentration (ugm / ml) 0 31.3 49.3 58.6 62.5 62.8 58.1 50.6 36.1 25.3 0 Time (hours) FACULTY OF SCIENCE Calculations Calculate the Tmax Tmax = (1/[ka-k]) ln (ka/k) Tmax = (1/[0.6742-0.0489]) ln (0.6742/0.0489) Tmax = (1/[0.6742-0.0489]) ln (13.8) Tmax = 1.6 x 2.6 Tmax = 4.2 mins FACULTY OF SCIENCE Nuclear Cardiology Case Study FACULTY OF SCIENCE Pharmacologic Stress • Exercise limited by beta blockers or calcium channel blocker • Stop xanthine drugs for 48 hours • Stop caffeine for 12-48 hours (varies) • We usually stop all stress patients with the caffeine ‘in case’ they need pharmacologic stress • Why? • For how long? • Lets ‘understand’ what we are doing. FACULTY OF SCIENCE Purines • Dipyridamole and Adenosine are not β agonists • Adenosine is a purine: • ATP breakdown • Present in many tissues (CNS and peripheral) • Acts on adenosine receptors (A1-4) • Blocked by theophylline • Vasodilator • Block AV conduction • Angina chest pain (stimulates nociceptive neurons) • Broncho-constriction (contraindicated in asthma) • Inhibits platelet aggregation • Neuroprotection in cerebral ischaemia FACULTY OF SCIENCE Adenosine FACULTY OF SCIENCE Adenosine There are four main adenosine receptor sub-types : • A1, block atrioventricular (AV) conduction, reduce force of cardiac contraction, decreased glomerular filtration rate, cardiac depression, renal vasoconstriction, decreased central nervous system (CNS) activity and bronchoconstriction. • A2A, anti-inflammatory response, vasodilation, decreased blood pressure, decreased CNS activity, inhibition of platelet aggregation and bronchodilation. • A2B, stimulate phospholipase activity, release of mast cell mediators, and actions on colon and bladder. • A3, stimulate phospholipase activity and release of mast cell mediators (contributes to bronchoconstriction). FACULTY OF SCIENCE Figure 2 Rest Stress adenosine reuptake inhibition (dipyridamole) coronary steal vasodilation – coronary flow reserve (adenosine) increased oxygen demand – induced ischaemia (exercise / dobutamine) FACULTY OF SCIENCE Adenosine and the Heart • A1 receptors • Causes transient heart block • Relax arterial smooth muscle • causes dilatation of the "normal" arteries • but not where affected by plaque • exaggerates blood flow difference between normal and stenosed vessels • Does not necessarily cause ischaemia • Short half life • Adenosine is also a CNS depressant! FACULTY OF SCIENCE Xanthine / Methylxanthines • Xanthine is a purine found throughout the body • two of the building blocks of DNA itself are structural analogues; adenine and guanine. • basic xanthine structure below • structural similarity with adenine part of adenosine means potential antagonism of adenosine by xanthine based drugs. • There are a number of xanthine derivatives that offer bronchodilation and mild CNS stimulation by virtue of antagonisms of adenosine. • Methylation (substitution of H with CH3) of the xanthine produces a number of variants called methylxanthines; caffeine, theobromine and theophylline. FACULTY OF SCIENCE Caffeine Theobromine Theophylline FACULTY OF SCIENCE Caffeine FACULTY OF SCIENCE FACULTY OF SCIENCE Caffeine • naturally occurring alkaloid • purine structure binds to same receptors as adenosine • effects of adenosine blunted by methylxanthines • caffeine, found in coffee and tea, • theobromine, found in chocolate • CNS stimulant • by blocking CNS depression by adenosine • respiratory stimulant • cardiac stimulant and diuretic FACULTY OF SCIENCE Caffeine in MPS • While 99% of caffeine is absorbed in the GI tract within 45 minutes of consumption, plasma concentrations following the same caffeine ingestion can vary amongst individuals by as much as a factor of 16 • The half life of caffeine is important but variable: • • • • • generally 4-6 hours biological half life increased a bit by oral contraceptives (x2) or pregnancy (15 hrs for last trimester) increased substantially (96 hours) in liver disease nicotine (smoking) can reduce the half life by 50% Alcohol consumption decreases half life FACULTY OF SCIENCE Caffeine in MPS • • • So why stop it for 48 hours? Because that represents 8-10 half lives. Same principle as decay by storage. • • Does it make a difference? The marginal improvement up to 24 hours is probably very worthwhile. The marginal improvement out to 48 hours (24-48 hrs) is probably negligible. • • • • Especially if they only have small amounts of caffeine. So for the average person, 24 hours is more than enough and indeed 12 hours would probably cover it. People addicted to coffee and chocolate might need longer. FACULTY OF SCIENCE Summary • Adenosine and persantin act on adenosine receptors so are not antagonised by β blockers • Exaggerates blood flow difference between normal and atherosclerotic vessels (vasodilation) • Causes bronchoconstriction • Persantin just increases the bioavailability of adenosine FACULTY OF SCIENCE Summary • • • • • Caffeine is an adenosine antagonist Need to stop for persantin or adenosine No need to stop for exercise or dobutamine 6-12 hours sufficient in normal use Longer in liver disease or heavy consumption • Shorter for smokers FACULTY OF SCIENCE Questions? FACULTY OF SCIENCE